We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
156 hedge funds and large institutions have $1.02B invested in Revance Therapeutics, Inc. in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 59 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
176% more call options, than puts
Call options by funds: $27.5M | Put options by funds: $9.97M
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
23% more capital invested
Capital invested by funds: $827M → $1.02B (+$188M)
3% more funds holding
Funds holding: 151 → 156 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
22% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 59
Holders
156
Holders Change
+5
Holders Change %
+3.31%
% of All Funds
2.46%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
46
Reduced
59
Closed
17
Calls
$27.5M
Puts
$9.97M
Net Calls
+$17.5M
Net Calls Change
+$15.6M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$9.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$5.96M |
| 3 |
D.E. Shaw & Co
New York
|
+$4.89M |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$4.03M |
| 5 |
Jennison Associates
New York
|
+$3.61M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$10.5M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$5.49M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$2.56M |
| 4 |
Goldman Sachs
New York
|
-$2.27M |
| 5 |
JP Morgan Chase
New York
|
-$1.66M |
